Postoperative Nausea and Vomiting in Plastic Surgery

ABSTRACT

Postoperative nausea and vomiting (PONV) is a common problem affecting nearly one third of all surgical patients. In addition to making the patient feel miserable, PONV is a major cause of prolonged recovery, unintended hospital admission, and poor patient satisfaction after surgery. Retching and vomiting can also lead to hematoma formation, wound and suture dehiscence, and aspiration. Thus, the prevention of PONV is an important goal in the overall outcome of surgery and, in particular, plastic surgery. The etiology of PONV is multifactorial, and several important risk factors have been identified. These factors include female gender, nonsmoking status, and a history of PONV or opioid-induced nausea and emesis. Volatile anesthetics and long operative duration also increase the risk of PONV. Reduction in the incidence of PONV requires careful assessment of patient-related risk factors as well as the appropriate use of prophylactic antiemetics. There are many antiemetic medications on the market today. Ondansetron, a serotonin 5-hydroxytryptamine antagonist, appears to be the current drug of choice for PONV prophylaxis. It has greatest efficacy and cost-effectiveness when used in patients at moderate to high risk. In addition, surgeons can consider using intravenous propofol or conscious sedation instead of general anesthesia where appropriate.

KEYWORDS

Postoperative - nausea - vomiting - emesis - PONV - antiemetic

REFERENCES

• 1 Apfel C C, Korttila K, Abdalla M et al.. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.  N Engl J Med. 2004;  350 2441-2451
• 2 Marcus J R, Few J W, Chao J D, Fine N A, Mustoe T A. The prevention of emesis in plastic surgery: a randomized, prospective study.  Plast Reconstr Surg. 2002;  109 2487-2494
• 3 Hirsch J. Impact of postoperative nausea and vomiting in the surgical setting.  Anaesthesia. 1994;  49 30-33
• 4 Macario A, Weinger M, Carney S, Kim A. Which clinical anesthesia outcomes are important to avoid? The prospective patients.  Anesth Analg. 1999;  89 652-658
• 5 Myles P S, Williams D L, Hendrata M et al.. Patient satisfaction after anesthesia and surgery: results of a prospective survey of 10811 patients.  Br J Anaesth. 2000;  84 6-10
• 6 Gan T, Sloan F, Dear G et al.. How much are patients willing to pay to avoid postoperative nausea and vomiting?.  Anesth Analg. 2001;  92 393-400
• 7 Marcus J R, Tyrone J W, Few J W, Fine N A, Mustoe T A. Optimization of conscious sedation in plastic surgery.  Plast Reconstr Surg. 1999;  104 1338-1345
• 8 Dingman R O. Severe bleeding during and after face-lifting operations under general anesthesia.  Plast Reconstr Surg. 1972;  50 608
• 9 Thompson D P, Ashley F L. Face-lift complications: a study of 922 cases performed in a 6-year period.  Plast Reconstr Surg. 1978;  61 40-49
• 10 Steely R L, Collins D R, Cohen B E, Bass K. Postoperative nausea and vomiting in the plastic surgery patient.  Aesthetic Plast Surg. 2004;  28 29-32
• 11 Williams K S. Postoperative nausea and vomiting.  Surg Clin North Am. 2005;  85 1229-1241
• 12 Watcha M F, White P F. Postoperative nausea and vomiting. Its etiology, treatment, and prevention.  Anesthesiology. 1992;  77 162-184
• 13 Tortorice P V, O'Connell M B. Management of chemotherapy-induced nausea and vomiting.  Pharmacotherapy. 1990;  10 129-145
• 14 Stadler M, Bardiau F, Seidel L et al.. Difference in risk factors for postoperative nausea and vomiting.  Anethesiology. 2003;  98 46-52
• 15 Apfel C C, Roewer N. Risk assessment of postoperative nausea and vomiting.  Int Anesthesiol Clin. 2003;  41 13-32
• 16 Cohen M M, Duncan P G, DeBoer D P et al.. The postoperative interview: assessing risk factors for nausea and vomiting.  Anesth Analg. 1994;  78 7-16
• 17 Sadhasivam S, Shende D, Madan R. Prophylactic ondansetron in prevention of postoperative nausea and vomiting following pediatric strabismus surgery: a dose-response study.  Anesthesiology. 2000;  92 1035-1042
• 18 Gurler T, Celik N, Totan S, Songur E, Sakarya M. Prophylactic use of ondansetron for emesis after craniofacial operations in children.  J Craniofac Surg. 1999;  10 45-48
• 19 Rose J B, Watcha M F. Postoperative nausea and vomiting in paediatric patients.  Br J Anaesth. 1999;  83 104-117
• 20 Stubbs T K, Saylors S, Jenkins M et al.. Pediatric patients experiencing postoperative nausea and vomiting after burn reconstruction surgery: an analysis.  J Burn Care Rehabil. 1999;  20 236-238
• 21 Apfel C C, Kranke P, Papenfufl T et al.. Volatile anaesthetics may be the main cause for early but not delayed postoperative nausea and vomiting: a randomized control trial of factorial design.  Br J Anaesth. 2002;  88 659-668
• 22 Unlugenc H, Guler T, Gunes Y, Isik G. Comparative study of the antiemetic efficacy of ondansetron, propofol, and midazolam in the early postoperative period.  Eur J Anaesthesiol. 2003;  20 668-673
• 23 Hasen K V, Samartzis D, Casas L A, Mustoe T A. An outcome study comparing intravenous sedation with midazolam/fentanyl (conscious sedation) versus propofol infusion (deep sedation) for aesthetic surgery.  Plast Reconstr Surg. 2003;  112 1683-1689
• 24 Watcha M F. The cost-effective management of postoperative nausea and vomiting [editorial; comment].  Anesthesiology. 2000;  92 931-933
• 25 Apfel C C, Laara E, Koivuranta M, Greim C A, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting.  Anesthesiology. 1999;  91 693-700
• 26 Apfel C C, Kranke P, Eberhart J. Comparison of surgical site and patient's history with a simplified risk score for the prediction of postoperative nausea and vomiting.  Anaesthesia. 2004;  59 1078-1082
• 27 Tang J, Wang B, White P F et al.. The effect of timing of ondansetron administration on its efficacy, cost-effectiveness, and cost-benefit as a prophylactic antiemetic in the ambulatory setting.  Anesth Analg. 1998;  86 274-282
• 28 Sadhasivam S, Saxena A, Kathirvel S et al.. The safety and efficacy of prophylactic ondansetron in patients undergoing modified radical mastectomy.  Anesth Analg. 1999;  89 1340-1345
• 29 Gan T J, Meyer T, Apfel C C et al.. Consensus guidelines for managing postoperative nausea and vomiting.  Anesth Analg. 2003;  97 62-71
• 30 Domino K B, Anderson E A, Polissar N L, Posner K L. Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis.  Anesth Analg. 1999;  88 1370-1379
• 31 Dabbous A, Itani M, Kawas N et al.. Post-laparoscopic vomiting in females versus males: comparison of prophylactic antiemetic action of ondansetron versus metoclopramide.  JSLS. 1998;  2 273-276
• 32 Malins A F, Field J M, Nesling P M, Coope G M. Nausea and vomiting after gynaecological laparoscopy: comparison of premedication with oral ondansetron, metoclopramide, and placebo.  Br J Anaesth. 1994;  72 231-233
• 33 Paxton L D, McKay A C, Mirakhur R K. Prevention of nausea and vomiting after day case gynaecological laparoscopy: a comparison of ondansetron, droperidol, metoclopramide, and placebo.  Anaesthesia. 1995;  50 403-406
• 34 Tang J, Watcha M F, White P F. A comparison of costs and efficacy of ondansetron and droperidol as prophylactic antiemetic therapy for elective outpatient gynecologic procedures.  Anesth Analg. 1996;  83 304-313
• 35 Barbosa M VJ, Nahas F X, Ferreira L M et al.. Ondansetron for the prevention of postoperative nausea and vomiting: which is the best dosage for aesthetic plastic surgery.  Aesthetic Plast Surg. 2004;  28 33-36
• 36 Sun R, Klein K W, White P F. The effect of timing of ondansetron administration in outpatients undergoing otolaryngologic surgery.  Anesth Analg. 1997;  84 331-336
• 37 White P F, Hamza M A, Recart A et al.. Optimal timing of acustimulation for antiemetic prophylaxis as an adjunct to ondansetron in patients undergoing plastic surgery.  Anesth Analg. 2005;  100 367-372
• 38 Kovac A L. Prophylaxis of postoperative nausea and vomiting: controversies in the use of serotonin 5-hydroxytryptamine subtype 3 receptor antagonists.  J Clin Anesth. 2006;  18 304-318
• 39 Cameron D, Gan T J. Management of postoperative nausea and vomiting in ambulatory surgery.  Anesthesiol Clin North Am. 2003;  21 347-365
• 40 Lim B S, Pavy T J, Lumsden G. The antiemetic and dysphoric effects of droperidol in the day surgery patient.  Anaesth Intensive Care. 1999;  27 371-374
• 41 Tramer M R, Walder B. Efficacy and adverse effects of prophylactic antiemetics during patient-controlled analgesia therapy.  Anesth Analg. 1999;  88 1354-1361
• 42 Tang J, Chen X, White P F et al.. Antiemetic prophylaxis for office-based surgery.  Anesthesiology. 2003;  98 293-298
• 43 Habib A S, Gan T J. The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report.  J Clin Anesth. 2005;  17 62-65
• 44 Williams O A, Clarke F L, Harris R W et al.. Addition of droperidol to patient-controlled analgesia: effect on nausea and vomiting.  Anaesthesia. 1993;  48 881-884
• 45 Approves F DA. EMEND^® (aprepitant), Merck's Antiemetic Therapy, for the Prevention of Postoperative Nausea and Vomiting. Available at: http://www.emend.com/aprepitant/emend/hcp/ponv/index.jsp Accessed July 31, 2006
• 46 American Society of Plastic Surgeons .Available at: http://www.plasticsurgery.org/new_room/press_releases/2004-Overall-Statistics.cfm Accessed July 15, 2006